Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in immunotherapy for triple-negative breast cancer
Yang Liu, Yueting Hu, Jinqi Xue, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

Inhibition of NF-κB signaling unveils novel strategies to overcome drug resistance in cancers
Yuanfang Li, Baiwei Zhao, Juzheng Peng, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101042-101042
Open Access | Times Cited: 26
Targeting triple negative breast cancer stem cells using nanocarriers
Nagasen Dasari, Girijasankar Guntuku, Sai Kiran S. S. Pindiprolu
Discover Nano (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 15
Inhibition of glycolysis-driven immunosuppression with a nano-assembly enhances response to immune checkpoint blockade therapy in triple negative breast cancer
Xijiao Ren, Zhuo Cheng, Jinming He, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 29
The immune checkpoint TIGIT/CD155 promotes the exhaustion of CD8 + T cells in TNBC through glucose metabolic reprogramming mediated by PI3K/AKT/mTOR signaling
Mingyao Huang, Xiaoqin Yu, Qing Wang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Epigenetic modulations in triple-negative breast cancer: Therapeutic implications for tumor microenvironment
Linlin Zhou, Danny Yu
Pharmacological Research (2024) Vol. 204, pp. 107205-107205
Open Access | Times Cited: 9
Breaking Barriers: The Promise and Challenges of Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer
Sawsan Sudqi Said, Wisam Nabeel Ibrahim
Biomedicines (2024) Vol. 12, Iss. 2, pp. 369-369
Open Access | Times Cited: 8
Autophagy in cancer immunotherapy: Perspective on immune evasion and cell death interactions
Qiang Yu, Jiajun Ding, Shisen Li, et al.
Cancer Letters (2024) Vol. 590, pp. 216856-216856
Closed Access | Times Cited: 8
Association of tumor-infiltrating lymphocytes with clinical outcomes in patients with triple-negative breast cancer receiving neoadjuvant chemotherapy: a systematic review and meta-analysis
Francisco Cézar Aquino de Moraes, Maria Eduarda Cavalcanti Souza, Vitor Kendi Tsuchiya Sano, et al.
Clinical & Translational Oncology (2024)
Closed Access | Times Cited: 7
Multifunctional ZnO@DOX/ICG-LMHP Nanoparticles for Synergistic Multimodal Antitumor Activity
Zhuoyue Li, Jingru Wang, Junwei Liu, et al.
Journal of Functional Biomaterials (2024) Vol. 15, Iss. 2, pp. 35-35
Open Access | Times Cited: 6
The microbiome: a link between obesity and breast cancer risk
Mohamed Gaber, Alana A. Arnone, Pierre‐Alexandre Vidi, et al.
Frontiers in Microbiomes (2024) Vol. 3
Open Access | Times Cited: 6
A mitochondria-interfering nanocomplex cooperates with photodynamic therapy to boost antitumor immunity
Zhijie Zhang, Qingfu Zhao, Qingqing Xu, et al.
Biomaterials (2025) Vol. 317, pp. 123094-123094
Closed Access
MORF4L2 induces immunosuppressive microenvironment and immunotherapy resistance through GRHL2/MORF4L2/H4K12Ac/CSF1 axis in triple-negative breast cancer
Xin-Yi Sui, Shuo-Wen Cao, Xiao-Qing Song, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Glycosylation profiling of triple-negative breast cancer: clinical and immune correlations and identification of LMAN1L as a biomarker and therapeutic target
Qianru Yu, Hanyi Zhong, Xinhao Zhu, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Mechanistic exploration of Traditional Chinese Medicine regulation on tumor immune microenvironment in the treatment of triple-negative breast cancer: based on CiteSpace and bioinformatics analysis
Dandan Feng, Dongqing Pu, Juan Ren, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Unveiling the role of MDH1 in breast cancer drug resistance through single-cell sequencing and schottenol intervention
Lü Jian, Feng Ding, Yongjie Sun, et al.
Cellular Signalling (2025), pp. 111608-111608
Closed Access
Gut microbiota interact with breast cancer therapeutics to modulate efficacy
Alana A. Arnone, Katherine Ansley, Arielle L. Heeke, et al.
EMBO Molecular Medicine (2025)
Open Access
Integrated Network Pharmacology, Machine Learning and Experimental Validation to Identify the Key Targets and Compounds of TiaoShenGongJian for the Treatment of Breast Cancer
Huiyan Ying, Weikaixin Kong, Xiangwei Xu
OncoTargets and Therapy (2025) Vol. Volume 18, pp. 49-71
Open Access
Targeted Modulation of the Meningeal Lymphatic Reverse Pathway for Immunotherapy of Breast Cancer Brain Metastases
Yanfeng Dai, Xiang Yu, Yifan Zhao, et al.
ACS Nano (2025)
Closed Access
(E)-1-(3-(3-Hydroxy-4-Methoxyphenyl)-1-(3,4,5-Trimethoxyphenyl)allyl)-1H-1,2,4-Triazole and Related Compounds: Their Synthesis and Biological Evaluation as Novel Antimitotic Agents Targeting Breast Cancer
Gloria Ana, Azizah M. Malebari, Sara Noorani, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 118-118
Open Access
Combination of adenosine blockade and ferroptosis for photo-immunotherapy of triple negative breast cancer with aptamer-modified copper sulfide
Xingyu Zhang, Chengyu Shi, Qiao Liu, et al.
Journal of Materials Chemistry B (2025)
Closed Access
Synergistic anti-tumor activity of ciclopirox olamine and metformin in triple-negative breast cancer
Yakun Wu, Hui Lyu, Congcong Tan, et al.
Genes & Diseases (2025), pp. 101538-101538
Open Access
A Self‐Amplifying Photodynamic Biomedicine for Cascade Immune Activation Against Triple‐Negative Breast Cancer
Xianquan Feng, Yan Zhang, Wanjing Lin, et al.
Small (2025)
Closed Access
The neuroscience in breast cancer: current insights and clinical opportunities
Jiafeng Wang, Meng-chuan Wang, Lei-lei Jiang, et al.
Heliyon (2025), pp. e42293-e42293
Open Access
Tumor Vascular Normalization by B7-H3 Blockade Augments T Lymphocyte-Mediated Antitumor Immunity
Xin Dai, Boran Cao, Xinnan Liu, et al.
European Journal of Pharmacology (2025), pp. 177334-177334
Closed Access
Platycodon grandiflorum-derived extracellular vesicles suppress triple-negative breast cancer growth by reversing the immunosuppressive tumor microenvironment and modulating the gut microbiota
Min Yang, Jia Guo, Jinxian Li, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top